Opn among MM patients [median (range) 85 (5-232) ng/ml] was higher than controls [36 (2-190) ng/ml] but the difference did not reach statistical significance.
← all excerpts
Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma.
1
—
—